Abstract

Purpose: Alzheimer disease (AD) is a progressive neurodegenerative disorder that is caused by neuroinflammation and oxidative stress. The present study aimed to characterize and then investigate the memory-enhancing potential of Viola odorata methanolic extract in lipopolysaccharide (LPS)–treated mice. Methods: V. odorata characterization was done by using the GCMS technique. Neuroinflammation was induced by the intracerebroventricular administration of LPS at a dose of 12 µg. Animals were divided randomly into six groups (n = 10). Group I was normal control, which was given vehicle. Group II was disease control, which received LPS (12 µg) via the intracerebroventricular route. Group III was standard, which was administered with donepezil (3 µg) orally for 21 days. Groups IV–VI were the treatment groups, which were administered with the extract at 100, 200, and 400 mg/kg dose levels orally respectively for 21 days. Groups III–VI received LPS (12 µg) on the first day along with their treatments. During the treatment, the animals were assessed for memory retention by employing different behavioral paradigms namely elevated plus maze, passive avoidance, foot shock and open field. Various mediators [endogenous antioxidants, neurotransmitters, and acetylcholinesterase (AChE)] involved in the pathogenesis of AD were quantified by using the UV spectrophotometric method. Results: Extract-treated groups showed a remarkable improvement in cognitive impairment in all behavioral paradigms. Oxidative stress biomarkers, that is, superoxide dismutase, catalase, and glutathione were raised dose-dependently in the treatment groups with a dose-dependent decrease in the malonaldehyde and AChE levels in the brains of the treated animals. The treatment groups showed decreased levels of inflammatory biomarkers, that is, tumor necrosis factor–alpha, nuclear factor kappa light-chain enhancer of activated β-cells, and cyclo-oxygenase, which supports the therapeutic effectiveness of the treatment. Conclusion: Based on behavioral, oxidative stress biomarker, and neuroinflammatory data, it is concluded that V. odorata possesses memory-enhancing activity and may prove a beneficial role in the management of AD.

Highlights

  • Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that commonly affects people older than 60 years (Wu et al, 2018)

  • V. odorata plant material was dried under shade for two weeks and ground electrically into a fine coarse powder

  • Phenolic contents were measured by using following regression line equation; y 0.6360x + 0.09263 (R2 0.9)

Read more

Summary

Introduction

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that commonly affects people older than 60 years (Wu et al, 2018). This results in the degeneration of the affected areas including the cingulate gyrus, frontal cortex, parietal lobe, temporal lobe, and hippocampus (Kumar and Singh, 2015). Deposits or aggregates of Aβ protein are formed in the initial stages of AD, which distorts the communication of neurons by causing neuroinflammation. Aβ proteins are responsible for the ineffective concentration of dopamine and norepinephrine, leading to cognitive dysfunction (Bitel et al, 2012). Another significant neurodegenerative pathway for AD is oxidative stress which results due to the overproduction of reactive oxygen species (ROS) and gradual loss of antioxidants defense mechanism. Plants are the major source of antioxidants; natural products can be a favorable therapeutic approach for AD (Saxena et al, 2008)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call